Clinical Trial Update: Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral Neuropathy [NA]

View source ↗

Summary

A clinical trial is evaluating the HILOTERM device for the prevention of peripheral neuropathy in breast cancer patients. The study status is not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Peripheral Neuropathy

Drugs mentioned

• HILOTERM

Snippet

Sponsor: European Institute of Oncology | Conditions: Breast Cancer, Neuropathy;Peripheral | NA | Status: NOT_YET_RECRUITING